Recruiting studies: Antiphospholipid Antibody Syndrome Primary

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)
Phase 2 · 1 location(s) · National and Kapodistrian University of Athens · NCT07584083 Evaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid Syndrome
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT06373926 Daratumumab in Primary Antiphospholipid Syndrome
Phase 1/Phase 2 · 8 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05671757 Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT05786235 Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
Phase N/A · 6 location(s) · Santé Arménie French-Armenian Research Center · NCT05904301 Effect of Belimumab on Antibody Titers in Primary APS Patients
Phase 2 · 1 location(s) · Ruijin Hospital · NCT06747312 Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Phase 1 · 1 location(s) · Polina Stepensky · NCT07085676

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.